Veradermics Financial Ratios
NYSE: MANEHealth CareBiotechnology: Pharmaceutical PreparationsUSD
130.90+4.27 (+3.37%)
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Veradermics ratio analysis
Valuation ratios use the closing share price on each fiscal year-end date and diluted shares from the income statement; profitability and leverage ratios use reported annual figures. Current valuation multiples are on the statistics page.
Summary generated from market data by MetaCap's automated system. Methodology
Veradermics financial ratios (annual)
| Ratio | FY 2025 | FY 2024 |
|---|---|---|
| Return on assets (ROA) | -45.9% | -47.7% |
| Current ratio | 16.66 | 11.77 |